News from NORD

FDA Orphan Product Grants Are Available


 

The Office of Orphan Products Development (OOPD) at the Food and Drug Administration (FDA) has posted information for those interested in applying for orphan product development grants. These are grants to support the clinical development of products for use in rare diseases or conditions for which no current therapy exists or when the product being developed will be superior to existing treatments.

Recommended Reading

Iron deficiency may explain persistent hypothyroidism symptoms
Clinician Reviews
NORD Releases First-Ever State Progress Report for Rare Diseases
Clinician Reviews
NIH NCATS Seeks Input for Strategic Plan
Clinician Reviews
NCATS Pre-Clinical Programs Now Accepting Collaborative Proposals
Clinician Reviews
FDA Orphan Product Grants Are Available
Clinician Reviews
NORD Releases First-Ever State Progress Report for Rare Diseases
Clinician Reviews
NIH NCATS Seeks Input for Strategic Plan
Clinician Reviews
NCATS Pre-Clinical Programs Now Accepting Collaborative Proposals
Clinician Reviews
Eczema Associated With Childhood Speech Disorder
Clinician Reviews
Suicide Rate High in Patients With Head and Neck Cancer
Clinician Reviews